Clinical Trial Update: GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial studying GVB-2001 gene therapy delivered via intracameral injection for primary open-angle glaucoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• GVB-2001 (GVB-2001)

Snippet

Sponsor: IVIEW Therapeutics Inc. | Conditions: Primary Open-Angle Glaucoma (POAG) | Phase 1, Phase 2 | Status: RECRUITING